The Global Stomach Cancer Market is poised for substantial growth as the burden of gastric malignancies continues to rise worldwide. Stomach cancer, also known as gastric cancer, remains one of the leading causes of cancer-related mortality, particularly in developing and densely populated regions. The market is expected to reach US$ 12,541 million by 2031, registering a strong CAGR of 14.9%...